Company Filing History:

4 out of 14

Syntex Pharmaceuticals, Ltd.

patents

Laroche Navarron S.a.

patents

Years Active: 1983-1996

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5545645 - Heterocyclic derivatives in the treatment of ischaemia and related (1996-08-13),

2. 5428037 - Heterocyclic derivatives in the treatment of Ischaemia and related (1995-06-27),

3. 5378847 - Process for the preparation of 1,2,4-substituted imidazoles and related (1995-01-03),

4. 5296609 - Process for the preparation of 1,2,4-substituted imidazoles and related (1994-03-22),

5. 5082847 - Carbostyril compounds connected via an oxyalkyl group with a piperidine (1992-01-21),

6. 4713382 - N-phenyl-4-phenyl-1-piperazinecarboxamidines and related compounds as (1987-12-15),

7. 4567264 - Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl (1986-01-28),

8. 4400381 - Piperazine derivatives of theophylline (1983-08-23),

9. 4374837 - Piperazine derivatives of theobromine (1983-02-22),

10. 4374835 - Piperazine derivatives of theophylline (1983-02-22),

Title: The Innovative Journey of Inventor Jean-Claude G Pascal

Introduction: Jean-Claude G Pascal is a distinguished inventor based in Cachan, France, renowned for his contributions to medicinal chemistry. With a remarkable portfolio of 10 patents, Pascal has significantly advanced treatment options for a variety of medical conditions.

Latest Patents: Among Pascal's latest innovations are the patents focusing on heterocyclic derivatives aimed at the treatment of ischaemia. Specific compounds disclosed in his patents are characterized by unique formulas that identify various substituents and configurations. These compounds act as calcium and sodium channel antagonists, proving effective in treating an array of medical conditions including stroke, epilepsy, hypertension, angina, migraine, arrhythmia, thrombosis, embolism, and spinal injuries. This pioneering work holds the potential to improve the quality of life for many patients suffering from these conditions.

Career Highlights: Throughout his career, Jean-Claude G Pascal has been associated with leading pharmaceutical companies such as Syntex Pharmaceuticals, Ltd. and Syntex (U.S.A.) Inc. His expertise and innovative spirit have played a pivotal role in advancing pharmaceutical research and development.

Collaborations: Pascal's contributions have been further enriched through collaborations with esteemed colleagues, including Gary McCourt and Dominique Blondet. These partnerships have fostered a dynamic exchange of ideas and expertise, enhancing the impact of their collective work in the field of medicine.

Conclusion: Jean-Claude G Pascal stands out as a prominent figure in the world of medicinal inventions. His innovative approaches and dedication to improving healthcare through scientific advancement reflect the significant role that inventors play in shaping the future of medicine. As he continues to develop new solutions for complex health issues, the legacy of his work will undoubtedly influence future generations of researchers and inventors.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.